Product analysis
St. John's Wort offers a focused herbal approach to mood support. It can weaken many medicines, making medication compatibility a key consideration.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
Hypericin identifies a component of the herb, but it does not establish an interchangeable extract preparation. The form quality remains uncertain.
Ingredient Transparency100
The herb amount and hypericin marker are declared. Those details clarify the stated ingredient without identifying every feature that distinguishes extracts.
Value For Money40
Value remains uncertain because a reliable ingredient cost comparison is unavailable. The stated herb amount alone does not establish whether the serving cost is worthwhile.
Customer Satisfaction66
Customer ratings are positive, although the review base is relatively small. The feedback gives a limited picture of satisfaction without establishing mood effects or medication suitability.
Product Focus67
The formula is focused on mood-related use, but supporting findings concern particular extracts and selected clinical settings. They do not establish routine mood benefits in healthy adults, and medication compatibility remains important.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.19
- Customer rating
- 4.4 · 172 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
St. John's Wort aerial part extract (Hypericin) | 300 mg |
How this ingredient is rated
Composition and Label Disclosure
Composition and Label Disclosure50
Explicit Label Detail
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- St John's wort for major depression.
- Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
- A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
- Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
- Complementary therapies for clinical depression: an overview of systematic reviews.